{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:43:58Z","timestamp":1794649438972,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The main focus on the characteristics of malignant lung tumours has been the size, position within the lobe, and infiltration into neighbouring structures. The aim of this study was to investigate the distribution and characteristics of malignant tumours between the lung lobes and whether the diagnosis, treatment, and outcome differed based on location.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is based on 10,849 lung cancer patients diagnosed in 2018\u20132022 with complete data on the location and characteristics of the tumours. The proportions of tumours in each lobe divided by its volume were termed the relative proportion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The right upper lobe comprised 31.2% of the tumours and 17.6% of the lung volume. The relative proportion of 1.77 was higher than in the other lobes (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The right middle lobe had a relative proportion of 0.64 but the highest proportion of neuroendocrine tumours (26.1% vs. 15.3 on average). Surgical resection was more often performed in patients with tumours in the lower lobes, and curative radiotherapy was more often performed in the upper lobes. After adjusting for age, sex, stage, and histology, the location of the tumour was found to be a significant independent predictor for resection but not for survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The main finding of the right upper lobe as a site of predilection for lung cancer is similar to tuberculosis and pneumoconiosis. This may be explained that most of the inhaled air, containing bacilli, inorganic particles or tobacco smoke goes to the upper and right parts of the lung.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-02918-w","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T11:01:36Z","timestamp":1709550096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Distribution and characteristics of malignant tumours by lung lobe"],"prefix":"10.1186","volume":"24","author":[{"given":"Yngvar","family":"Nilssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd Terje","family":"Brustugun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fjellbirkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5slaug","family":"Helland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sissel Gyrid Freim","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Solberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"1","key":"2918_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"10","key":"2918_CR2","doi-asserted-by":"publisher","first-page":"e0223298","DOI":"10.1371\/journal.pone.0223298","volume":"14","author":"K Gu","year":"2019","unstructured":"Gu K, Lee HY, Lee K, Choi JY, Woo SY, Sohn I, Kim HK, Choi YS, Kim J, Zo JI, et al. Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung. PLoS ONE. 2019;14(10):e0223298.","journal-title":"PLoS ONE"},{"issue":"4","key":"2918_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1067\/mtc.2001.116473","volume":"122","author":"Y Ichinose","year":"2001","unstructured":"Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M, Tsuboi M. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg. 2001;122(4):803\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"2918_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/thx.2005.056481","volume":"61","author":"TE Strand","year":"2006","unstructured":"Strand TE, Rostad H, M\u00f8ller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax. 2006;61(8):710\u20135.","journal-title":"Thorax"},{"issue":"2","key":"2918_CR5","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/j.cllc.2016.09.001","volume":"18","author":"N Shaverdian","year":"2017","unstructured":"Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Location matters: stage I non-small-cell carcinomas of the lower lobes treated with stereotactic body Radiation Therapy are Associated with Poor outcomes. Clin Lung Cancer. 2017;18(2):e137\u201342.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"2918_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11748-019-01205-4","volume":"68","author":"M Tamura","year":"2020","unstructured":"Tamura M, Matsumoto I, Tanaka Y, Saito D, Yoshida S, Takata M, Takemura H. Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2020;68(3):261\u20135.","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"2918_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/carcin\/bgv168","volume":"37","author":"CH Tseng","year":"2016","unstructured":"Tseng CH, Chen KC, Hsu KH, Tseng JS, Ho CC, Hsia TC, Su KY, Wu MF, Chiu KL, Liu CM, et al. EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis. 2016;37(2):157\u201362.","journal-title":"Carcinogenesis"},{"issue":"12","key":"2918_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/1759-7714.12869","volume":"9","author":"HW Lee","year":"2018","unstructured":"Lee HW, Lee CH, Park YS. Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis. Thorac cancer. 2018;9(12):1614\u201322.","journal-title":"Thorac cancer"},{"issue":"1","key":"2918_CR9","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1038\/s41598-020-71996-7","volume":"10","author":"HW Lee","year":"2020","unstructured":"Lee HW, Park YS, Park S, Lee CH. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations. Sci Rep. 2020;10(1):14933.","journal-title":"Sci Rep"},{"key":"2918_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","volume":"6","author":"G da Cunha Santos","year":"2011","unstructured":"da Cunha Santos G, Shepherd FA, Tsao MS. EGFR mutations and lung cancer. Annu Rev Pathol. 2011;6:49\u201369.","journal-title":"Annu Rev Pathol"},{"key":"2918_CR11","volume-title":"The investigation of the relative function of the right and left lung by broncho-spirometry. Technique, physiology and application","author":"F Bergan","year":"1957","unstructured":"Bergan F. The investigation of the relative function of the right and left lung by broncho-spirometry. Technique, physiology and application. New York \/ London: Grune & Stratton Inc; 1957."},{"issue":"7","key":"2918_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1159\/000507265","volume":"99","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, Niijima Y, Narita K, Nakahara T, Murata M, Fukunaga K, et al. Differences in lung and lobe volumes between Supine and Standing positions scanned with conventional and newly developed 320-Detector-row upright CT: intra-individual comparison. Respiration. 2020;99(7):598\u2013605.","journal-title":"Respiration"},{"key":"2918_CR13","unstructured":"Corryn B, Nicholoson A. Pathology Og the lungs. 3rd ed. Churchill Livingston Elsevier; 2011."},{"issue":"7","key":"2918_CR14","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, Sm\u00e5stuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, M\u00f8ller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218\u201331.","journal-title":"Eur J Cancer"},{"key":"2918_CR15","unstructured":"The Cancer Registry of Norway. Cancer nor 2022 [https:\/\/www.kreftregisteret.no\/globalassets\/cancer-in-norway\/2022\/cin_report-2022.pdf]."},{"key":"2918_CR16","unstructured":"The Cancer Registry of Norway. National quality register for Lung Cancer 2022. [https:\/\/www.kreftregisteret.no\/Generelt\/Rapporter\/Arsrapport-fra-kvalitetsregistrene\/Arsrapport-for-lungekreft\/arsrapport-for-lungekreft-2022\/]."},{"issue":"4","key":"2918_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"2918_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1536867X1501500112","volume":"15","author":"PW Dickman","year":"2015","unstructured":"Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15:186\u2013215.","journal-title":"Stata J"},{"issue":"1","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","volume":"68","author":"MP Perme","year":"2012","unstructured":"Perme MP, Stare J, Est\u00e8ve J. On estimation in relative survival. Biometrics. 2012;68(1):113\u201320.","journal-title":"Biometrics"},{"key":"2918_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1536867X1501500111","volume":"15","author":"E Coviello","year":"2015","unstructured":"Coviello E, Dickman PW, Sepp\u00e4 K, Pokhrel A. Estimating ne surviving using life-table approach. Stata J. 2015;15:173\u201385.","journal-title":"Stata J"},{"key":"2918_CR21","first-page":"182","volume":"98","author":"K Liavaag","year":"1949","unstructured":"Liavaag K. Bronchiogenic Carcinoma. Acta Chir Scand. 1949;98:182\u2013204.","journal-title":"Acta Chir Scand"},{"issue":"7955","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","volume":"616","author":"W Hill","year":"2023","unstructured":"Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, Kuan FC, Marongiu F, Evans EJ Jr., Moore DA, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159\u201367.","journal-title":"Nature"},{"issue":"4","key":"2918_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/thx.2010.151621","volume":"66","author":"CM Sagerup","year":"2011","unstructured":"Sagerup CM, Sm\u00e5stuen M, Johannesen TB, Helland \u00c5, Brustugun OT. Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax. 2011;66(4):301\u20137.","journal-title":"Thorax"},{"issue":"3","key":"2918_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ccm.2021.04.007","volume":"42","author":"LT Tanoue","year":"2021","unstructured":"Tanoue LT. Women and Lung Cancer. Clin Chest Med. 2021;42(3):467\u201382.","journal-title":"Clin Chest Med"},{"key":"2918_CR25","unstructured":"Holst J, Semb C, Frimann-Dahl J. On the surgical treatment of pulmonary tuberculosis. Nathionaltrykkeriet, Oslo; 1935."},{"key":"2918_CR26","volume-title":"Robbins Basic Pathology","author":"V Kumar","year":"2007","unstructured":"Kumar V, Abbas A, Fausto N, Mitchell R. Robbins Basic Pathology. Philadelphia, PA: Saunders Elsevier; 2007."},{"issue":"4004","key":"2918_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/bmj.2.4004.650","volume":"2","author":"C Semb","year":"1937","unstructured":"Semb C. Thoracoplasty with Extrafascial Apicolysis. Br Med J. 1937;2(4004):650\u201366654.","journal-title":"Br Med J"},{"key":"2918_CR28","first-page":"213","volume":"124","author":"C Semb","year":"1962","unstructured":"Semb C. Surgical treatment of pulmonary tuberculosis. Acta Chir Scand. 1962;124:213\u201328.","journal-title":"Acta Chir Scand"},{"key":"2918_CR29","unstructured":"Kumar. V, Abbas. A. J A: Robbins Basic Pathology. 10th ed. Elsevier; 2017."},{"issue":"3","key":"2918_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1152\/jappl.1966.21.3.749","volume":"21","author":"J Milic-Emili","year":"1966","unstructured":"Milic-Emili J, Henderson JA, Dolovich MB, Trop D, Kaneko K. Regional distribution of inspired gas in the lung. J Appl Physiol. 1966;21(3):749\u201359.","journal-title":"J Appl Physiol"},{"issue":"5","key":"2918_CR31","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/ijc.27339","volume":"131","author":"B Pesch","year":"2012","unstructured":"Pesch B, Kendzia B, Gustavsson P, J\u00f6ckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Br\u00fcske I, et al. Cigarette smoking and lung cancer\u2013relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210\u20139.","journal-title":"Int J Cancer"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-02918-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:22:38Z","timestamp":1709932958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-02918-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-02918-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been carried out in accordance with the guidelines in Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The transfer of data to the CRN is mandatory by law for all hospitals. No patient contact has been necessary for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the Cancer Registry of Norway is statutory, no consent is needed to present data on group basis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Steinar Solberg received grant (#212426) from The Norwegian Cancer Society. \u00c5slaug Helland received Research support from AstraZeneca, Roche, Novartis, Incyte, EliLilly, BMS, Ultimovacs, the Norwegian Cancer Society, The regional health authorities in Norway. Have given talks and advise to pharma companies, and all honoraries are going to the hospital (Astra, Roche, Janssen, Novartis, Takeda, Pfizer, BMS, EliLilly, Abbvie, Merck, Sanofi). The other authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}